In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization

Yan-Qin Shen1, Guillaume Hebert, Yun Su

  • 1Department of Microbiology and Immunology, Shantou University Medical College, 22 Xinling Road, Shantou 515031, Guangdong, PR China.

Brain Research
|May 25, 2005
PubMed

Insights

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) increases plasma cytokines IL-1beta and IL-6 in mice. This MPTP-induced cytokine elevation is influenced by behavioral lateralization, impacting dopamine levels and immune responses.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes dopaminergic neuron death, mimicking Parkinson disease pathology.
  • MPTP exposure affects both central nervous system cytokines and peripheral immune parameters.
  • Previous research indicates that cytokine production can be influenced by behavioral lateralization.

Purpose of the Study:

  • To investigate whether MPTP administration elevates plasma cytokine levels in mice.
  • To determine if MPTP-induced plasma cytokine changes are associated with behavioral lateralization.
  • To examine the relationship between MPTP, dopamine levels, and behavioral lateralization.

Main Methods:

  • C57BL/6J male mice, selected for paw preference, received daily MPTP injections (25 mg/kg) for five consecutive days.
  • Mice were euthanized at 1, 3, or 14 days post-injection.
  • Striatal dopamine (DA) and DOPAC concentrations were measured using High-Performance Liquid Chromatography (HPLC).
  • Plasma levels of Interleukin-1 beta (IL-1beta) and Interleukin-6 (IL-6) were quantified via Enzyme-Linked Immunosorbent Assay (ELISA).

Main Results:

  • MPTP treatment significantly decreased striatal DA content.
  • Plasma IL-1beta levels increased by day 3, while IL-6 levels elevated by day 14 post-MPTP injection.
  • Behavioral lateralization modulated the MPTP effects: left-pawed mice showed a greater decrease in the DA/DOPAC ratio, increased IL-1beta, and lower IL-6 elevation compared to right-pawed mice.

Conclusions:

  • MPTP administration leads to increased plasma levels of IL-1beta and IL-6 in mice.
  • The observed elevation in plasma cytokines following MPTP exposure is significantly shaped by the animal's behavioral lateralization.
  • These findings suggest a complex interplay between neurotoxicity, immune response, and lateralization in the context of Parkinson disease models.

Related Concept Videos